IMPLANON (etonogestrel) · Merck
IMPLANON is FDA-approved to treat 1 condition (same as NEXPLANON).
Details
- Status
- Discontinued
- First Approved
- 2006-07-17
- Patent Cliff
- 2030
- Routes
- IMPLANTATION
- Dosage Forms
- IMPLANT
IMPLANON Approval History
What IMPLANON Treats
1 indicationsIMPLANON is approved for 1 conditions since its original approval in 2006. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Prevention of pregnancy
Same approved indications as NEXPLANON (same active ingredient).
Merck's other novel FDA approvals
Other CDER-designated drugs from the same sponsor (2016–2025).
Clinical Trial Registry
4 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT00651807 | P05806 304001 | Ph 2 | terminated | A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806) |
| NCT03978598 LACTO-Rod results posted | 19-049 | Ph 4 | completed | Breastfeeding Etonogestrel Implant Study |
| NCT02082652 | PRO14010195 | Ph 4 | completed | A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy |
| NCT02480647 | 44827415200005404 | Ph 4 | completed | Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
IMPLANON FDA Label Details
Indications & Usage
FDA Label (PDF)IMPLANON is FDA-approved to treat 1 condition — same approved indications as NEXPLANON.
IMPLANON Patents & Exclusivity
Patents (4 active)
Exclusivity
Pro Intelligence Preview
Deep insights for IMPLANON
Revenue Insights
- • Quarterly revenue tracking
- • Historical trend analysis
Patent Timeline
- • Cliff: 2030
- • 5 active patents
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • Competitor tracking
- • Same target/indication analysis
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.